Back
Fundraising
MedTech/BioTech
2024

Advanced Life Solutions Fundraising

THM Capital Advisory supports Advanced Life Solutions in the raising of the second installment of its Series A.

Activity

Created by Silvina Ramella, a recognized scientist in organ transplantation and ex-CEO of a leading European company in the sector, Advanced Life Solutions is developing Perla®, a new liquid for the preservation and protection of grafts.

Perla® aims to improve the functional recovery of transplanted organs and to extend their lifespan.

The solution was designed to better protect more fragile grafts, especially from older donors.

Preservative fluids currently used in transplantation have existed for 30 to 40 years and are less suitable for this type of organ more”Sensitive”, which are now more frequently available.

Objectives

After a first installment in 2022, Advanced Life Solutions is raising €2.5 million (second Series A installment) to finance its development in Europe and the United States.

Investors

The two family offices already invested in the first phase (2022) are leading this round.

THM Capital Advisory Team
Thomas Mitard
Managing Partner
Aurélien Prost
Associate